Changes in 5-HT2A -mediated behavior and 5-HT2A - and 5-HT1A receptor binding and expression in conditional brain-derived neurotrophic factor knock-out mice

Abstract Changes in brain-derived neurotrophic factor (BDNF) expression have been implicated in the etiology of psychiatric disorders. To investigate pathological mechanisms elicited by perturbed BDNF signaling, we examined mutant mice with central depletion of BDNF (BDNF2L/2LCk-cre ). A severe impa...

Full description

Saved in:
Bibliographic Details
Published inNeuroscience Vol. 169; no. 3; pp. 1007 - 1016
Main Authors Klein, A.B, Santini, M.A, Aznar, S, Knudsen, G.M, Rios, M
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier Ltd 01.09.2010
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Changes in brain-derived neurotrophic factor (BDNF) expression have been implicated in the etiology of psychiatric disorders. To investigate pathological mechanisms elicited by perturbed BDNF signaling, we examined mutant mice with central depletion of BDNF (BDNF2L/2LCk-cre ). A severe impairment specific for the serotonin 2A receptor (5-HT2A R) in prefrontal cortex was described previously in these mice. This is of much interest, as 5-HT2A Rs have been linked to neuropsychiatric disorders and anxiety-related behavior. Here we further characterized the serotonin receptor alterations triggered by BDNF depletion. 5-HT2A ([3 H]-MDL100907) and 5-HT1A ([3 H]-WAY100635) receptor autoradiography revealed site-specific alterations in BDNF mutant mice. They exhibited lower 5-HT2A receptor binding in frontal cortex but increased binding in hippocampus. Additionally, 5-HT1A receptor binding was decreased in hippocampus of BDNF mutants, but unchanged in frontal cortex. Molecular analysis indicated corresponding changes in 5-HT2A and 5-HT1A mRNA expression but normal 5-HT2C content in these brain regions in BDNF2L/2LCk-cre mice. We investigated whether the reduction in frontal 5-HT2A R binding was reflected in reduced functional output in two 5-HT2A -receptor mediated behavioral tests, the head-twitch response (HTR) and the ear-scratch response (ESR). BDNF2L/2LCk-cre mutants treated with the 5-HT2A receptor agonist (±)-2,5-dimethoxy-4-iodoamphetamine (DOI) showed a clearly diminished ESR but no differences in HTR compared to wildtypes. These findings illustrate the context-dependent effects of deficient BDNF signaling on the 5-HT receptor system and 5-HT2A -receptor functional output.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0306-4522
1873-7544
DOI:10.1016/j.neuroscience.2010.05.054